The following pages link to Barbara Jarząb (Q16531491):
Displaying 50 items.
- Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA (Q28118792) (← links)
- Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas (Q28275066) (← links)
- Genome-wide association study on differentiated thyroid cancer (Q28943543) (← links)
- Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours (Q30313129) (← links)
- Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. (Q30313796) (← links)
- A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas. (Q30317054) (← links)
- Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas (Q30317493) (← links)
- Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. (Q30992731) (← links)
- Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues. (Q31141133) (← links)
- Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. (Q33215949) (← links)
- Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal (Q33463820) (← links)
- Analysis options for high-throughput sequencing in miRNA expression profiling (Q33557722) (← links)
- Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells (Q33890655) (← links)
- B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression (Q33934897) (← links)
- Association between polymorphisms in the TSHR gene and Graves' orbitopathy. (Q33951536) (← links)
- 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study (Q34018753) (← links)
- Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review). (Q34035598) (← links)
- Cabozantinib in progressive medullary thyroid cancer (Q34185084) (← links)
- Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma (Q34276843) (← links)
- The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report (Q34331382) (← links)
- Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi (Q34341331) (← links)
- Molecular changes in thyroid neoplasia (Q34512677) (← links)
- Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. (Q34716574) (← links)
- Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma (Q34778280) (← links)
- Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. (Q34989774) (← links)
- Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk (Q35160562) (← links)
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (Q35195766) (← links)
- Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective (Q35649218) (← links)
- The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors (Q35692478) (← links)
- Current genetic methodologies in the identification of disaster victims and in forensic analysis (Q35693617) (← links)
- Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features (Q35819975) (← links)
- Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies. (Q35852853) (← links)
- BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma (Q35857363) (← links)
- Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset. (Q35946146) (← links)
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues (Q36037071) (← links)
- rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. (Q36078981) (← links)
- Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy (Q36239261) (← links)
- A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas (Q36299076) (← links)
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report (Q36302100) (← links)
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review (Q36328600) (← links)
- A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping (Q36410621) (← links)
- Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. (Q36431628) (← links)
- Is there a need to redefine the upper normal limit of TSH? (Q36462681) (← links)
- Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer? (Q36643368) (← links)
- A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment (Q36716739) (← links)
- Association between age at diagnosis of Graves' disease and variants in genes involved in immune response (Q36721277) (← links)
- Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. (Q36757987) (← links)
- SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility (Q36817184) (← links)
- Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. (Q36834614) (← links)
- Gene signature of the post-Chernobyl papillary thyroid cancer (Q36908328) (← links)